ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	12 December 2020
Main ID:	NCT02273791
Date of registration:	19/10/2014
Prospective Registration:	No
Primary sponsor:	Mansoura University
Public title:	HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients
Scientific title:	Hormone Replacement Therapy Versus Minimal Ovarian Stimulation for Endometrial Preparation Prior to Frozen-thawed Embryo Transfer in Polycystic Ovarian Syndrome Patients
Date of first enrolment:	December 2013
Target sample size:	126
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT02273791
Study type:	Observational
Study design:
Phase:

Countries of recruitment
Egypt

Contacts

Name:	Mohamed I Eid, Dr
Address:
Telephone:
Email:
Affiliation:	Mansoura University

Name:	Ahmed Badawy, Prof
Address:
Telephone:
Email:
Affiliation:	Mansoura University

Name:	Mohamed S Abdelhafez, Dr
Address:
Telephone:
Email:
Affiliation:	Mansoura University

Name:	Maher S Elsegaey, Dr
Address:
Telephone:
Email:
Affiliation:	Mansoura University

Name:	Mahmoud M Abdelrazik, Dr
Address:
Telephone:
Email:
Affiliation:	Mansoura University

Key inclusion & exclusion criteria

Inclusion Criteria:

- Women with PCOS as defined by the Rotterdam criteria.

- Presence of at least 2 cryopreserved good quality cleavage-stage embryo (good quality
cleavage-stage embryos display stage-specific cell division, have blastomeres of
fairly equal size with few to no cytoplasmic fragments).

Exclusion Criteria:

- Moderate or severe endometriosis.

- Hydrosalpinx.

- Uterine abnormalities or myoma.

- Previous uterine surgery.

Age minimum: 20 Years
Age maximum: 38 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Polycystic Ovarian Syndrome

Infertility

Intervention(s)

Drug: Sequential Clomiphene citrate and Gonadotropin

Drug: Estradiol valerate

Primary Outcome(s)

Clinical pregnancy rate [Time Frame: 6 weeks after embryo transfer]

Secondary Outcome(s)

Miscarriage rate [Time Frame: 12 weeks gestational age]

Implantation rate [Time Frame: 6 weeks after embryo transfer]

Secondary ID(s)

MSA1

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.